Gonski to replace Morschel at the top of ANZ

Shareholders are expected to appoint the renowned business leader at tomorrow's AGM.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The board of ANZ Banking Group (ASX: ANZ) will look to add former solicitor and Australian business leader, David Gonski AC to the company's top role.

According to a media release today, the board of directors of ANZ have chosen Mr Gonski – who was a former ANZ director from 2002 to 2007 – to take the reins from current chairman John Morschel in May 2014.

Mr Gonski is an accomplished business leader and has a number of current positions at prominent Australian institutions including chairman of Coca-Cola Amatil (ASX: CCL). He also has roles at the Guardians of the Future Fund, Investec Bank (Australia) and as a director of Singapore Telecommunications (ASX: SGT). In addition to senior positions in Australian businesses he is also Chancellor of the University of New South Wales, chairman of the Sydney Theatre Company, and a director of Infrastructure NSW and of the Lowy Institute for International Policy.

"Mr Gonski will join the ANZ Board in February 2014. After relinquishing some of his current commitments he will assume the Chair in May 2014," ANZ said in its media release.

It appears ANZ has provided shareholders with a competent and experienced leader to succeed Mr Morschel as it continues to grow operations in Asia to counteract slower lending growth in Australia and New Zealand. "David's business experience in Australia and in Asia, and his broad range of involvement with government and with the education and community sectors will be a significant asset for ANZ," Mr Morschel said.

"It is a privilege to succeed John as chairman having had a strong relationship with ANZ over many years. The bank is in a strong position and I am looking forward to working with shareholders, with my fellow directors, and with Mike Smith and his management team to continue to realise ANZ's super regional strategy," Mr Gonski said.

Foolish takeaway

In past 12 months ANZ has recruited a number of senior leaders and is restructuring itself as it continues to push heavily into Asian markets. ANZ has the right strategy, people and the financial strength to see it succeed in delivering long term shareholder value.

Motley Fool contributor Owen Raszkiewicz does not have a financial interest in any of the mentioned companies. 

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »